{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:27:59Z","timestamp":1793633279083,"version":"4.5.1"},"reference-count":215,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI104681"],"award-info":[{"award-number":["UM1 AI104681"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI157981"],"award-info":[{"award-number":["U19 AI157981"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32 AR56950"],"award-info":[{"award-number":["T32 AR56950"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2022,3,15]]},"abstract":"<jats:p>Increasing antimicrobial resistance and medical device-related infections have led to a renewed interest in phage therapy as an alternative or adjunct to conventional antimicrobials. Expanded access and compassionate use cases have risen exponentially but have varied widely in approach, methodology, clinical situations in which phage therapy might be considered, dosing, route of administration, and outcomes.<\/jats:p>","DOI":"10.1128\/aac.02071-21","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T20:16:47Z","timestamp":1642537007000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":405,"title":["Considerations for the Use of Phage Therapy in Clinical Practice"],"prefix":"10.1128","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7434-6897","authenticated-orcid":true,"given":"Gina A.","family":"Suh","sequence":"first","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4730-0655","authenticated-orcid":true,"given":"Thomas P.","family":"Lodise","sequence":"additional","affiliation":[{"name":"Albany College of Pharmacy and Health Sciences, Albany, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-6324","authenticated-orcid":true,"given":"Pranita D.","family":"Tamma","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Knisely","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Alexander","sequence":"additional","affiliation":[{"name":"Advent Health, Orlando, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Aslam","sequence":"additional","affiliation":[{"name":"University of California San Diego, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen D.","family":"Barton","sequence":"additional","affiliation":[{"name":"Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Bizzell","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8181-1176","authenticated-orcid":true,"given":"Katherine M. C.","family":"Totten","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Campbell","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K.","family":"Chan","sequence":"additional","affiliation":[{"name":"Yale University, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Goodman","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerryl E.","family":"Greenwood-Quaintance","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Harris","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-1858","authenticated-orcid":true,"given":"Shayla","family":"Hesse","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Maresso","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Nussenblatt","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8161-6015","authenticated-orcid":true,"given":"David","family":"Pride","sequence":"additional","affiliation":[{"name":"University of California San Diego, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2220-0081","authenticated-orcid":true,"given":"Michael J.","family":"Rybak","sequence":"additional","affiliation":[{"name":"College of Pharmacy &amp; Health Sciences and School of Medicine, Wayne State University, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Sund","sequence":"additional","affiliation":[{"name":"Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4784-3227","authenticated-orcid":true,"given":"David","family":"van Duin","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-0103","authenticated-orcid":true,"given":"Daria","family":"Van Tyne","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6344-4141","authenticated-orcid":true,"given":"Robin","family":"Patel","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Antibacterial Resistance Leadership Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03306"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy073"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11010007"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2009.04353.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz782"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2012.05432.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa389"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01281-19"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1747950"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.029744-0"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30330-3"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2019.1191"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2009.01973.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01696"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9070377"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30482-1"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01600.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2008.06.023"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7915.2011.00259.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-019-01319-0"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24945"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmic.2018.05.001"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0437-z"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15503"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01403-9"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1902754"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201904-0839LE"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnv246"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-017-0050-1"},{"key":"e_1_3_2_31_2","first-page":"569","article-title":"Results of bacteriophage treatment of suppurative bacterial infections in the years 1981\u20131986","volume":"35","author":"Slopek S","year":"1987","unstructured":"Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A. 1987. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981\u20131986. Arch Immunol Ther Exp (Warsz) 35:569\u2013583.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"e_1_3_2_32_2","first-page":"547","article-title":"Bacteriophage therapy of bacterial infections: an update of our institute's experience","volume":"48","author":"Weber-Dabrowska B","year":"2000","unstructured":"Weber-Dabrowska B, Mulczyk M, Gorski A. 2000. Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch Immunol Ther Exp (Warsz) 48:547\u2013551.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz222"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy064"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa705"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202113936"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/v11100891"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00342"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy269"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky263"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00924-19"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.569159"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.570572"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030231"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13061182"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9050241"},{"key":"e_1_3_2_47_2","first-page":"597","article-title":"Successful bacteriophage treatment of infection involving cardiac implantable electronic device and aortic graft: a Trojan horse concept. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the","volume":"22","author":"Exarchos V","year":"2020","unstructured":"Exarchos V, Tkhilaishvili T, Potapov E, Starck C, Trampuz A, Schoenrath F. 2020. Successful bacteriophage treatment of infection involving cardiac implantable electronic device and aortic graft: a Trojan horse concept. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the. Eur Soc Cardiol 22:597.","journal-title":"Eur Soc Cardiol"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.01.001"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezz295"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.05.027"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9050232"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/emph\/eoy005"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50274"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(03)00525-6"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00954-17"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pix056"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0634-z"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1709-y"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874364101509010167"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep26717"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-26736-0_13"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13071268"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.692614"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7395-8_14"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2006.02.012"},{"key":"e_1_3_2_66_2","first-page":"11","article-title":"A case series of emergency investigational new drug applications for bacteriophages treating recalcitrant multi-drug resistant bacterial infections: confirmed safety and a signal of efficacy","volume":"5","author":"Duplessis CASM","year":"2019","unstructured":"Duplessis CASM, Hamilton T, Merril G, Brownstein M, et al. 2019. A case series of emergency investigational new drug applications for bacteriophages treating recalcitrant multi-drug resistant bacterial infections: confirmed safety and a signal of efficacy. J Intensive Crit Care 5:11.","journal-title":"J Intensive Crit Care"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01832"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25190"},{"key":"e_1_3_2_69_2","unstructured":"United States Code. 2018. Title 21. Food and drugs. Chapter 9. Federal food drug and cosmetics act. Subchapter V. Drugs and devices. Part A. Drugs and devices. https:\/\/www.law.cornell.edu\/uscode\/text\/21\/chapter-9\/subchapter-V\/part-A."},{"key":"e_1_3_2_70_2","unstructured":"United States Code. 2018. Title 42. The public health and welfare. Chapter 6A. Public Health Service. Subchapter II. General powers and duties. Part F. Licensing of biological products and clinical laboratories. Subpart 1. Biological products. Section 262. Regulation of biological products. https:\/\/www.law.cornell.edu\/uscode\/text\/42\/262."},{"key":"e_1_3_2_71_2","unstructured":"Code of Federal Regulations. 2021. Title 21. Food and drugs. Chapter I. Food and Drug Administration. Subchapter D. Drugs for human use. Part 312. Investigational new drug application. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=312."},{"key":"e_1_3_2_72_2","unstructured":"Code of Federal Regulations. 2021. Title 21. Food and drugs. Chapter I. Food and Drug Administration. Subchapter D. Drugs for human use. Part 312. Investigational new drug application. Section 312.23(7). IND content and format. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=312.23."},{"key":"e_1_3_2_73_2","unstructured":"Reference deleted."},{"key":"e_1_3_2_74_2","unstructured":"Code of Federal Regulations. 2021. Title 21. Food and drugs. Chapter I. Food and Drug Administration. Subchapter D. Drugs for human use. Part 312. Investigational new drug application. Section 312.305. Requirements for all expanded access uses. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=312.305."},{"key":"e_1_3_2_75_2","volume-title":"Expanded access. How to submit a request (forms).","author":"Food and Drug Administration","unstructured":"Food and Drug Administration. Expanded access. How to submit a request (forms). Food and Drug Administration, Washington, DC. https:\/\/www.fda.gov\/news-events\/expanded-access\/expanded-access-how-submit-request-forms."},{"key":"e_1_3_2_76_2","unstructured":"Code of Federal Regulations. 2021. Title 21. Food and drugs. Chapter I. Food and Drug Administration. Subchapter D. Drugs for human use. Part 312. Investigational new drug application. Section 312.310. Individual patients including for emergency use. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=312.310."},{"key":"e_1_3_2_77_2","unstructured":"Code of Federal Regulations. 2021. Title 21. Food and drugs. Chapter I. Food and Drug Administration. Subchapter D. Drugs for human use. Part 312. Investigational new drug application. Section 312.32. IND safety reporting. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=312.32."},{"key":"e_1_3_2_78_2","unstructured":"Code of Federal Regulations. 2021. Title 21. Food and drugs. Chapter I. Food and Drug Administration. Subchapter D. Drugs for human use. Part 312. Investigational new drug application. Section 312.33. Annual reports. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=312.33."},{"key":"e_1_3_2_79_2","volume-title":"For physicians: how to request single patient expanded access (\u201ccompassionate use\u201d).","author":"Food and Drug Administration","unstructured":"Food and Drug Administration. For physicians: how to request single patient expanded access (\u201ccompassionate use\u201d). Food and Drug Administration, Washington, DC. https:\/\/www.fda.gov\/drugs\/investigational-new-drug-ind-application\/physicians-how-request-single-patient-expanded-access-compassionate-use."},{"key":"e_1_3_2_80_2","volume-title":"Demonstrating substantial evidence of effectiveness for human drug and biological products.","author":"Food and Drug Administration","unstructured":"Food and Drug Administration. Demonstrating substantial evidence of effectiveness for human drug and biological products. Food and Drug Administration, Washington, DC. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/demonstrating-substantial-evidence-effectiveness-human-drug-and-biological-products."},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-765X.2007.02190.x"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00229-19"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2013.10.034"},{"key":"e_1_3_2_84_2","volume-title":"Bacteriophages: biology and Application.","author":"Carlson K","year":"2004","unstructured":"Carlson K. 2004. Bacteriophages: biology and Application. CRC Press, Boca Raton, FL."},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.4161\/bact.1.2.15456"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02170"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-017-0266-5"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep14802"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-164-6_14"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.4161\/bact.1.1.13980"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86571-x"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.594868"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1385\/MB:26:2:133"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep16532"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00211-21"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03474-20"},{"key":"e_1_3_2_97_2","first-page":"165","article-title":"Efficacy of combinations of piperacilline\/tazobactam, ceftazidime, amikacin and bacteriophage against Enterobacteriaceae sepsis in neonates: in vitro study","volume":"11","author":"Abdul-Jabar HH","year":"2020","unstructured":"Abdul-Jabar HH, Abd AH, Abdulamir AS. 2020. Efficacy of combinations of piperacilline\/tazobactam, ceftazidime, amikacin and bacteriophage against Enterobacteriaceae sepsis in neonates: in vitro study. Syst Rev Pharm 11:165\u2013170.","journal-title":"Syst Rev Pharm"},{"key":"e_1_3_2_98_2","first-page":"186","article-title":"Efficacy of bacteriophage-antibiotic combinations against Staphylococcus aureus infection: in vitro study","volume":"30","author":"Ali HMH","year":"2015","unstructured":"Ali HMH, Abd AKH, Abdulameer AS, Taha RN. 2015. Efficacy of bacteriophage-antibiotic combinations against Staphylococcus aureus infection: in vitro study. Int J Pharm Sci Rev Res 30:186\u2013189.","journal-title":"Int J Pharm Sci Rev Res"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168615"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32344-y"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmic.2012.08.008"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01462-20"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2020.0083"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1093\/femsec\/fiw211"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmic.2018.04.008"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02850-14"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw632"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056022"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06688-w"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.3390\/v6103778"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00461-20"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/eva.12364"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-4571.2012.00248.x"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051017"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00993-20"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40598-8_52-1"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.2436\/20.1501.01.292"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8030103"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02231-19"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13369-016-2194-3"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9110749"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.3390\/v11100954"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00127"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-019-0315-0"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.K.01135"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216292"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2016.12.013"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0169-z"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-091919-074551"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.3390\/v11010010"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1038\/246221a0"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2017.06.018"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-009-0044-2"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10110617"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.7.2874-2878.2005"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01681"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02607"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00414"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000658"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts014"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01283"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004679200"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3527"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10040188"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07910-5"},{"key":"e_1_3_2_146_2","unstructured":"United States Food and Drug Administration. 2008. Guidance for industry. CGMP for phase 1 investigational drugs. https:\/\/www.fda.gov\/media\/70975\/download."},{"key":"e_1_3_2_147_2","unstructured":"United States Food and Drug Administration. 2012. Guidance of industry: pyrogen and endotoxin testing: questions and answers. https:\/\/www.fda.gov\/media\/83477\/download."},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01209"},{"key":"e_1_3_2_149_2","unstructured":"American Pharmaceutical Review. 2018. Setting endotoxin acceptance criteria for biologics intravenous (IV) and subcutaneous (SC) mono- and combination therapies. https:\/\/www.americanpharmaceuticalreview.com\/Featured-Articles\/353671-Setting-Endotoxin-Acceptance-Criteria-for-Biologics-Intravenous-IV-and-Subcutaneous-SC-Mono-and-Combination-Therapies\/#:\u223c:text=Drug%20product%20endotoxin%20acceptance%20criteria %2Fhour%20for%20intrathecal%20administration."},{"key":"e_1_3_2_150_2","unstructured":"United States Food and Drug Administration. 2018. FDA alerts health care professionals of significant safety risks associated with cesium chloride. https:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/PharmacyCompounding\/ucm614211.htm."},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(16)34214-9"},{"key":"e_1_3_2_152_2","first-page":"253","article-title":"Preparation of endotoxin-free bacteriophages","volume":"9","author":"Boraty\u0144ski J","year":"2004","unstructured":"Boraty\u0144ski J, Syper D, Weber-Dabrowska B, \u0141usiak-Szelachowska M, Po\u017aniak G, G\u00f3rski A. 2004. Preparation of endotoxin-free bacteriophages. Cell Mol Biol Lett 9:253\u2013259.","journal-title":"Cell Mol Biol Lett"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01674"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.09.018"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.05.048"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2010.12.083"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122672"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102600"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01198"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.6.1292"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-394621-8.00017-0"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac00206a012"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2019.113354"},{"key":"e_1_3_2_164_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro822"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.21775\/cimb.040.081"},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.11.5557-5564.2002"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.109520"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01352"},{"key":"e_1_3_2_169_2","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.590"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.538060"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920110790725410"},{"key":"e_1_3_2_172_2","doi-asserted-by":"publisher","DOI":"10.1039\/C7TB01302G"},{"key":"e_1_3_2_173_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.07.006"},{"key":"e_1_3_2_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.07.014"},{"key":"e_1_3_2_175_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10020064"},{"key":"e_1_3_2_176_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01161"},{"key":"e_1_3_2_177_2","doi-asserted-by":"publisher","DOI":"10.3390\/v11040352"},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-020-0346-0"},{"key":"e_1_3_2_179_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02537"},{"key":"e_1_3_2_180_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw083"},{"key":"e_1_3_2_181_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00012-19"},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.21572"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2013.0128"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.1128\/aem.49.1.19-23.1985"},{"key":"e_1_3_2_185_2","doi-asserted-by":"publisher","DOI":"10.1080\/21597081.2016.1220348"},{"key":"e_1_3_2_186_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-387044-5.00001-7"},{"key":"e_1_3_2_187_2","doi-asserted-by":"publisher","DOI":"10.1080\/03009734.2019.1688433"},{"key":"e_1_3_2_188_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2007.11.003"},{"key":"e_1_3_2_189_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.9705.1"},{"key":"e_1_3_2_190_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2009.00125.x"},{"key":"e_1_3_2_191_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2008.11.002"},{"key":"e_1_3_2_192_2","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24689"},{"key":"e_1_3_2_193_2","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12673"},{"key":"e_1_3_2_194_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2213-4"},{"key":"e_1_3_2_195_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2008.0701"},{"key":"e_1_3_2_196_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10379"},{"key":"e_1_3_2_197_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2012.06.012"},{"key":"e_1_3_2_198_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1193"},{"key":"e_1_3_2_199_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01874-17"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2017.05.014"},{"key":"e_1_3_2_201_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101841"},{"key":"e_1_3_2_202_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-020-04794-w"},{"key":"e_1_3_2_203_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.03.009"},{"key":"e_1_3_2_204_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.07.014"},{"key":"e_1_3_2_205_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy678"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2010.05.014"},{"key":"e_1_3_2_207_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047742"},{"key":"e_1_3_2_208_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1691-x"},{"key":"e_1_3_2_209_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.018580-0"},{"key":"e_1_3_2_210_2","first-page":"134","article-title":"Protection with bacteriophage K\u00d81 against fatal Klebsiella pneumoniae-induced burn wound infection in mice","volume":"42","author":"Malik R","year":"2009","unstructured":"Malik R, Chhibber S. 2009. Protection with bacteriophage K\u00d81 against fatal Klebsiella pneumoniae-induced burn wound infection in mice. J Microbiol Immunol Infect 42:134\u2013140.","journal-title":"J Microbiol Immunol Infect"},{"key":"e_1_3_2_211_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220421"},{"key":"e_1_3_2_212_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01257-10"},{"key":"e_1_3_2_213_2","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.178615"},{"key":"e_1_3_2_214_2","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.312"},{"key":"e_1_3_2_215_2","doi-asserted-by":"publisher","DOI":"10.3390\/v7082845"},{"key":"e_1_3_2_216_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy947"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.02071-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.02071-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T15:06:16Z","timestamp":1647356776000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.02071-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":215,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,15]]}},"alternative-id":["10.1128\/aac.02071-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.02071-21","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"2022-03-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02071-21"}}